Boston Financial Management’s CONMED CNMD Stock Holding History

Boston Financial Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$219K	Hold	3,197	–	–	0.01%	319
2024 Q3	$230K	Hold	3,197	–	–	0.01%	305
2024 Q2	$222K	Hold	3,197	–	–	0.01%	313
2024 Q1	$256K	Hold	3,197	–	–	0.01%	302
2023 Q4	$350K	Hold	3,197	–	–	0.01%	271
2023 Q3	$322K	Hold	3,197	–	–	0.01%	259
2023 Q2	$434K	Sell	3,197 -12	-0.4%	-$1.47K	0.02%	243
2023 Q1	$333K	Hold	3,209	–	–	0.01%	262
2022 Q4	$284K	Hold	3,209	–	–	0.01%	274
2022 Q3	$257K	Hold	3,209	–	–	0.01%	273
2022 Q2	$307K	Sell	3,209 -16	-0.5%	-$1.92K	0.01%	245
2022 Q1	$479K	Hold	3,225	–	–	0.02%	207
2021 Q4	$457K	Hold	3,225	–	–	0.02%	197
2021 Q3	$422K	Hold	3,225	–	–	0.02%	197
2021 Q2	$443K	Sell	3,225 -11	-0.3%	-$1.51K	0.02%	191
2021 Q1	$423K	Hold	3,236	–	–	0.02%	184
2020 Q4	$362K	Hold	3,236	–	–	0.02%	192
2020 Q3	$255K	Hold	3,236	–	–	0.01%	221
2020 Q2	$233K	Sell	3,236 -30	-0.9%	-$2.09K	0.01%	218
2020 Q1	$187K	Buy	3,266 +30	+0.9%	+$2.77K	0.01%	232
2019 Q4	$362K	Buy	+3,236	New	+$345K	0.02%	196

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Boston Financial Management's CNMD Position: Q4 2024 in Review

Boston Financial Management held its CONMED (CNMD) position steady in Q4 2024 at 3,197 shares worth $219K. The position accounts for 0.01% of the portfolio, ranked #319.

Boston Financial Management first reported a position in CNMD in Q4 2019 and has held it in 21 quarters since. The position peaked at $479K in Q1 2022. 280 funds tracked by Wall St. Rank hold CNMD as of Q4 2024.

Boston Financial Management held 3,197 shares of CONMED worth $219K as of Q4 2024.
Boston Financial Management left its CONMED share count unchanged in Q4 2024.
CONMED made up 0.01% of Boston Financial Management's portfolio in Q4 2024, its #319 holding.
Boston Financial Management first reported a position in CONMED in Q4 2019 and has held it in 21 quarters since.
Boston Financial Management's CONMED position peaked at $479K in Q1 2022.
280 funds tracked by Wall St. Rank held CONMED as of Q4 2024.

Based on Boston Financial Management's 13F filing for Q4 2024, filed 3 Feb 2025.